Company Overview
Snapshot
Founded in January 1984, Savyon Diagnostics operates with 11–50 employees, specializing in diagnostic kits and systems. In May 2020, the company introduced its NA Lysis Buffer, expanding its product offerings in infectious disease detection.
Business overview
Savyon Diagnostics develops, manufactures, and markets diagnostic kits and systems for the detection of infectious diseases and genetic screening. The company's core technology utilizes various immunological and molecular biology techniques, including ELISA, lateral flow, RT-PCR, MIF, and IPA. Savyon Diagnostics serves global markets through a network of distributors and also provides contract manufacturing and development services to biotechnology companies, ranging from startups to large enterprises, primarily operating within the Health Tech & Life Sciences sector.
Strategic signal
In May 2020, Savyon Diagnostics launched its NA Lysis Buffer, a strategic move that enhances its portfolio of diagnostic solutions. This product introduction signals the company's ongoing commitment to innovation in infectious disease detection and its efforts to maintain relevance in the evolving health tech and life sciences market.
Log in to access full profile ›Company Intelligence Q&A
- What is Savyon Diagnostics' primary focus?
- Savyon Diagnostics focuses on the development, manufacturing, and marketing of diagnostic kits and systems for infectious diseases and genetic screening.
- When was Savyon Diagnostics founded?
- Savyon Diagnostics was founded in January 1984.
- What significant product did Savyon Diagnostics introduce in 2020?
- In May 2020, Savyon Diagnostics introduced its NA Lysis Buffer, a product designed to enhance its diagnostic solutions for infectious disease detection.
- Does Savyon Diagnostics offer contract services?
- Yes, Savyon Diagnostics offers contract manufacturing and development services to biotechnology companies.
- What was the news regarding a bladder cancer diagnosis kit in 2002?
- In May 2002, Prochon and Savyon Diagnostics announced plans to develop a bladder cancer diagnosis kit.